Allergy Relief
- Product NDC
- 55681-322
- Requested package NDC
- 55681-322-03
- 11-digit product format
- 556810322
- Labeler code
- 55681
- Product ID
- 55681-322_e4a47143-2d18-d1ba-e053-2a95a90a17cc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Diphenhydramine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- TWIN MED LLC
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-07-15
- Marketing end
- 0000-00-00
- Substance
- DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 55681-322 | 55681-322-03 | D | Discontinued by firm | 2026-10-12 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 55681-322-03 | 55681032203 | 300 TABLET in 1 BOTTLE (55681-322-03) | 300 tablet | 2022-07-15 | 0000-00-00 | No | No | Current |